Media Summary: Anastasia Khvorova, PhD, of University of Massachusetts Medical School presents an update on progress for a Recorded on May 25, 2023 at Waters IMMERSE Cambridge. SiRNA Therapy for MECP2 Duplication Syndrome

Webinar M2ds Therapeutics Sirna Project - Detailed Analysis & Overview

Anastasia Khvorova, PhD, of University of Massachusetts Medical School presents an update on progress for a Recorded on May 25, 2023 at Waters IMMERSE Cambridge. SiRNA Therapy for MECP2 Duplication Syndrome In May 2026, members of the Antibiotic Expert Group presented on updates to Subscribe for the latest science breakdowns! And, become a member to chat 1:1 about science related topics! Dr. Huda Zoghbi has made critical contributions to the MECP2 Duplication Syndrome (MDS) field. Among the most important has ...

Speaker: Joy Wolfram, MS, Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX (USA); CAS ...

Photo Gallery

WEBINAR | M2DS Therapeutics: siRNA Project Updates & Next Steps
Progress Update: siRNA Based Compounds to Treat MECP2 Duplication Syndrome
Designing siRNAs for improving their therapeutic applications
Bioconjugation/Bioanalytical/Immunogen/ADME/Quant Clin Pharm for siRNA ASO Nucleic Acid Therapeutics
"LC UV/MS Analysis of Nucleic Acid Therapeutics: Oligonucleotides, siRNA, and mRNA" by Martin Gilar.
SiRNA Therapy for MECP2 Duplication Syndrome
Webinar: SRP-9001 Gene Therapy Path Forward (November 2020)
Re-engineering the guidelines | Ms Melanie Rosella | ASID preconference symposium 2026
What is siRNA Technology?
Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modification
Webinar: SRP-9001 Data Update from Studies 101, 102, and 103 (August 2022)
Developing an Antisense Oligonucleotide Therapeutic for MECP2 Duplication Syndrome
View Detailed Profile
WEBINAR | M2DS Therapeutics: siRNA Project Updates & Next Steps

WEBINAR | M2DS Therapeutics: siRNA Project Updates & Next Steps

RSRT hosts a

Progress Update: siRNA Based Compounds to Treat MECP2 Duplication Syndrome

Progress Update: siRNA Based Compounds to Treat MECP2 Duplication Syndrome

Anastasia Khvorova, PhD, of University of Massachusetts Medical School presents an update on progress for a

Designing siRNAs for improving their therapeutic applications

Designing siRNAs for improving their therapeutic applications

Small interfering RNAs (

Bioconjugation/Bioanalytical/Immunogen/ADME/Quant Clin Pharm for siRNA ASO Nucleic Acid Therapeutics

Bioconjugation/Bioanalytical/Immunogen/ADME/Quant Clin Pharm for siRNA ASO Nucleic Acid Therapeutics

Webinar

"LC UV/MS Analysis of Nucleic Acid Therapeutics: Oligonucleotides, siRNA, and mRNA" by Martin Gilar.

"LC UV/MS Analysis of Nucleic Acid Therapeutics: Oligonucleotides, siRNA, and mRNA" by Martin Gilar.

Recorded on May 25, 2023 at Waters IMMERSE Cambridge.

SiRNA Therapy for MECP2 Duplication Syndrome

SiRNA Therapy for MECP2 Duplication Syndrome

SiRNA Therapy for MECP2 Duplication Syndrome

Webinar: SRP-9001 Gene Therapy Path Forward (November 2020)

Webinar: SRP-9001 Gene Therapy Path Forward (November 2020)

Parent

Re-engineering the guidelines | Ms Melanie Rosella | ASID preconference symposium 2026

Re-engineering the guidelines | Ms Melanie Rosella | ASID preconference symposium 2026

In May 2026, members of the Antibiotic Expert Group presented on updates to

What is siRNA Technology?

What is siRNA Technology?

Subscribe for the latest science breakdowns! And, become a member to chat 1:1 about science related topics!

Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modification

Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modification

Ken Yamada - Extended Nucleic Acid

Webinar: SRP-9001 Data Update from Studies 101, 102, and 103 (August 2022)

Webinar: SRP-9001 Data Update from Studies 101, 102, and 103 (August 2022)

PPMD invited Sarepta

Developing an Antisense Oligonucleotide Therapeutic for MECP2 Duplication Syndrome

Developing an Antisense Oligonucleotide Therapeutic for MECP2 Duplication Syndrome

Dr. Huda Zoghbi has made critical contributions to the MECP2 Duplication Syndrome (MDS) field. Among the most important has ...

Multistage Delivery of siRNA Therapeutics

Multistage Delivery of siRNA Therapeutics

Speaker: Joy Wolfram, MS, Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX (USA); CAS ...